KELLY EMERTON, PhD
Science and Business Advisor
Senior Director of Product Development for Cleveland Clinic Innovations
Dr. Emerton runs product development for medical device technologies originating in Cleveland Clinic. She also sits on CWRU’s Technology Validation Start-up Fund committee, is on the Medical/Scientific Advisory Board for Temple Therapeutics, and is currently the Chief Executive Officer of Tatara Vascular, LLC, a medical device spin-off technology under Cleveland Clinic which has raised over $1.5 million and received regulatory clearance on a guidewire family, as well as she is the Business Lead for Cleveland Clinic’s newest spin-off company for obstructive sleep apnea, Enhale Medical, Inc. She lends her expertise from 10+ years in product development, formerly with Medtronic, where she led the Endovascular Therapies division’s thoracic pipeline portfolio.